|
KOREA LIFE SCIENCE
|
DHLAB
|
Liquid Handling Automation Equipment,capping decapping automation equipment, Barcode reader equipment, Barcode vial, Barcode Rack Box, SBS Tube, DeepFreezer
|
C52
|
|
KOREA LIFE SCIENCE
|
DKNC CO., LTD.
|
Mini-SEM, Digital Microscope, Auto Focusing Microscope (LUSIS202)
|
F31
|
|
PARTNERING
|
Dongguk University Medical Center
|
Dongguk University Medical Center
|
H60
|
|
KOREA LAB Autumn
|
DONGWON CNS EDU
|
Microscope
|
G31
|
|
KOREA LIFE SCIENCE
|
Draeger Korea
|
Chemical suits, Gas detectors, Masks, PAPR
|
G46
|
|
KOREA LIFE SCIENCE
|
Duksan Pure Chemicals
|
High Purity Solvent, Bio Solvent
|
D32
|
|
KOREA LIFE SCIENCE
|
Eflow Co., LTD
|
Cobetter Microfilter, TFF, Single Use Bag, Sterile Filter, Depth Filter,Lab Membrane, Syringe, Centrifuge UF, Vacuum Filter
|
D12
|
|
NextRegenX
|
einocle Inc.
|
Single-Cell Multi-Omics Analysis Platform
|
B23
|
|
PARTNERING
|
elegslab lnc.
|
The AI-C. elegans-based drug discovery platform is a nonclinical CRO technology that utilizes AI to analyze the responses of C. elegans to drug candidates, thereby assessing their toxicity and efficacy. The C. elegans model occupies a unique position in areas such as reproductive toxicity, metabolic disorders, neurodegenerative diseases, and age-related conditions, where cell-based assays and organoid analyses are not feasible. As such, it offers a distinct competitive advantage as a nonclinical CRO in these specialized fields. C. elegans enables the collection of large-scale data from numerous individuals, and its short life cycle facilitates rapid data acquisition. It is possible to reduce both the time and cost of drug development by leveraging big data-driven predictive models.
|
C60
|
|
PARTNERING
|
EMOTIV
|
Digital Mental Health Solutions & Therapeutic Devices
|
E41
|
KYUNGYON EXHIBITION CORP.